Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study

作者：Juan W. Valle, Arndt Vogel, Crystal S. Denlinger, Aiwu Ruth He, Li‐Yuan Bai, Р. В. Орлова, Eric Van Cutsem, Jorge Adeva, Li‐Tzong Chen, Radka Obermannová, Thomas J. Ettrich, Jen‐Shi Chen, Harpreet Wasan, Allicia C. Girvan, Wei Zhang, Jiangang Liu, Chunlao Tang, Philip J. Ebert, Amit Aggarwal, Samuel McNeely, Brian A. Moser, Joana Oliveira, Roberto Carlesi, Richard A. Walgren, Do‐Youn Oh · 发表于：The Lancet Oncology · 年份：2021 · DOI：10.1016/s1470-2045(21)00409-5 · 被引用次数：68 · 研究领域：Cholangiocarcinoma and Gallbladder Cancer Studies、Gallbladder and Bile Duct Disorders、Pancreatic and Hepatic Oncology Research